Risk Factors of Gout in MDR-TB Patients in Eritrea: A Case-Control Study

Table 1

Comparing the baseline characteristics of the case and control groups.

Variable Name	Cases	Controls	P-value
Total No. Patients	42	42
Ethnicity
Tigrigna	32	36	0.522^+
Tigre	4	2
Others	6	4
Any Comorbidity
No	36	42	0.026^+
Yes	6	0
Mean (SD)
Age	40.57 (13.78)	39.43 (15.22)	0.719^++
Weight	43.38 (9.55)	43.69 (11.24)	0.892^++
Drug Exposure (Months)	20.33 (6.12)	19.43 (7.44)	0.544^++
Number of Drugs	7.05 (1.03)	6.62 ( 0.73)	0.031^++
Onset of gout	5.71 (5.34)
Gout Phase (Median, Range)	1.0 (1 - 2)

⁺The p-values were obtained from a chi-square goodness of fit test. For those with a cell count of zero, p-value was obtained after applying a continuity adjustment. ⁺⁺The p-value was obtained from a two-sample t-test.